Literature DB >> 24667724

Lapatinib concentration in cerebrospinal fluid in two patients with HER2-positive metastatic breast cancer and brain metastases.

S Gori1, G Lunardi1, A Inno2, J Foglietta3, B Cardinali4, L Del Mastro4, L Crinò3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24667724     DOI： 10.1093/annonc/mdu041

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  10 in total

Review 1.  Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.

Authors:  Megan O Jacus; Vinay M Daryani; K Elaine Harstead; Yogesh T Patel; Stacy L Throm; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

2.  Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.

Authors:  Gaia Griguolo; Stephane Pouderoux; Maria Vittoria Dieci; William Jacot; Céline Bourgier; Federica Miglietta; Nelly Firmin; Pierfranco Conte; Marie Viala; Valentina Guarneri; Amélie Darlix
Journal:  Oncologist       Date:  2018-08-17

Review 3.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.

Authors:  Marc C Chamberlain; Christina S Baik; Vijayakrishna K Gadi; Shailender Bhatia; Laura Q M Chow
Journal:  Neuro Oncol       Date:  2017-01       Impact factor: 12.300

Review 4.  Leptomeningeal Metastases: New Opportunities in the Modern Era.

Authors:  Jessica A Wilcox; Min Jun Li; Adrienne A Boire
Journal:  Neurotherapeutics       Date:  2022-07-05       Impact factor: 7.620

5.  Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases.

Authors:  Jing Li; Jun Jiang; Xun Bao; Vineet Kumar; Stephen C Alley; Scott Peterson; Anthony J Lee
Journal:  Clin Cancer Res       Date:  2022-08-02       Impact factor: 13.801

Review 6.  Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.

Authors:  Minjee Kim; Sani H Kizilbash; Janice K Laramy; Gautham Gampa; Karen E Parrish; Jann N Sarkaria; William F Elmquist
Journal:  Pharm Res       Date:  2018-07-12       Impact factor: 4.200

Review 7.  Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.

Authors:  Jan-Paul Bohn; Georg Pall; Guenther Stockhammer; Michael Steurer
Journal:  Target Oncol       Date:  2016-06       Impact factor: 4.493

Review 8.  Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatment.

Authors:  Taeryool Koo; In Ah Kim
Journal:  Radiat Oncol J       Date:  2016-03-30

9.  The influence of the coadministration of the p-glycoprotein modulator elacridar on the pharmacokinetics of lapatinib and its distribution in the brain and cerebrospinal fluid.

Authors:  Agnieszka Karbownik; Katarzyna Sobańska; Włodzimierz Płotek; Tomasz Grabowski; Agnieszka Klupczynska; Szymon Plewa; Edmund Grześkowiak; Edyta Szałek
Journal:  Invest New Drugs       Date:  2019-06-08       Impact factor: 3.850

10.  Neuroprotective Effects of the Anti-cancer Drug Lapatinib Against Epileptic Seizures via Suppressing Glutathione Peroxidase 4-Dependent Ferroptosis.

Authors:  Ji-Ning Jia; Xi-Xi Yin; Qin Li; Qi-Wen Guan; Nan Yang; Kang-Ni Chen; Hong-Hao Zhou; Xiao-Yuan Mao
Journal:  Front Pharmacol       Date:  2020-12-10       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.